European LeukemiaNet 2020 recommendations for treating chronic myeloid leukemia
2020 · Leukemia · 1,470 citations
https://doi.org/10.1038/s41375-020-0776-2
F
François Guilhot
Inserm(FR)
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
625
Papers
42.8K
Citations
84
h-index
296
i10-index
François Guilhot is an academic researcher from Inserm. The author has contributed to research in topics: Chronic Myeloid Leukemia Treatments & Chronic Lymphocytic Leukemia Research & Eosinophilic Disorders and Syndromes. The author has an h-index of 84, co-authored 532 publications.
ORCID: 0000-0001-7222-487XPapers by this author
worksEvidence for eomesodermin‐expressing innate‐like CD8<sup>+</sup> KIR/NKG2A<sup>+</sup> T cells in human adults and cord blood samples
2015 · European Journal of Immunology · 102 citations
https://doi.org/10.1002/eji.201545539
Novel Insights into Interleukin 6 (IL-6) Cis- and Trans-signaling Pathways by Differentially Manipulating the Assembly of the IL-6 Signaling Complex
2015 · Journal of Biological Chemistry · 66 citations
https://doi.org/10.1074/jbc.m115.682138
Alternative donor hematopoietic stem cell transplantation for mature lymphoid malignancies after reduced-intensity conditioning regimen: similar outcomes with umbilical cord blood and unrelated donor peripheral blood
2013 · Haematologica · 54 citations
https://doi.org/10.3324/haematol.2013.088997
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
2021 · British Journal of Haematology · 42 citations
https://doi.org/10.1111/bjh.17654
Personalized Daily Doses of Imatinib By Therapeutic Drug Monitoring Increase the Rates of Molecular Responses in Patients with Chronic Myeloid Leukemia. Final Results of the Randomized OPTIM Imatinib Study
2015 · Blood · 33 citations
https://doi.org/10.1182/blood.v126.23.133.133
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat